{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-046207","form_type":"8-K","ticker":"XWEL","cik":"0001410428","company_name":"XWELL, Inc.","filed_at":"2023-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.755812+00:00","generated_at":"2026-06-17T01:18:34.996467+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"XWELL reports FY2022 net loss of $32.8M vs net income of $3.3M prior year; revenue down 24% to $55.9M","bullets":["Total revenue $55.9M in FY2022, down from $73.7M in FY2021; net loss attributable to common shareholders $32.8M vs net income $3.3M.","Loss from operations $31.2M vs income $4.1M; cost of sales up to $43.9M from $41.4M; G&A expenses $31.2M vs $24.2M.","Repurchased ~19.5M shares for $23.8M; 0.8M shares remain under existing buyback program.","Opened 5 XpresSpa at Istanbul Airport; plans Abu Dhabi opening in Q3 2023 and new spa at Philadelphia Airport in 2023.","Expanded CDC biosurveillance partnership with Ginkgo Bioworks to include influenza monitoring; closed underperforming XpresCheck and Treat locations."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-046207","json":"https://secwatch.observer/filing/0001104659-23-046207.json","markdown":"https://secwatch.observer/filing/0001104659-23-046207.md","text":"https://secwatch.observer/filing/0001104659-23-046207.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1410428/000110465923046207/0001104659-23-046207-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1410428/000110465923046207/tm2313030d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T01:18:34.996467+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"813cd29384f83152ae7dc54e7ffdcfe6feee24f1","claim":"XWELL, Inc. reported financial results for the year ended December 31, 2022.","evidence_excerpt":"today reported results for the year ended December 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1410428/000110465923046207/0001104659-23-046207-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}